- Published on
Emergency and Acute Medicine – Community-Acquired MRSA
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) represents a shift from the traditional healthcare-associated MRSA infections that primarily affected elderly or chronically ill patients with frequent medical exposures. Over the past decade, CA-MRSA has emerged as a common pathogen among younger, otherwise healthy individuals without recent healthcare contact. It is now the most frequent cause of skin and soft tissue infections presenting to the emergency department. Although CA-MRSA most often causes localized skin disease, it can also result in severe, life-threatening illnesses such as sepsis and necrotizing pneumonia.
Staphylococcus aureus is a gram-positive cocci that commonly colonizes the skin and nares. MRSA refers to strains that have developed resistance to methicillin and many other β-lactam antibiotics. Certain populations are at increased risk for colonization and infection, including prisoners, athletes, military personnel, children in daycare, people who inject drugs, and individuals with prior MRSA infections or close contact with colonized or infected persons. In contrast, healthcare-associated MRSA remains more prevalent among elderly patients, particularly those in long-term care facilities or with frequent healthcare exposure.
Patients with CA-MRSA most commonly present with skin and soft tissue infections characterized by increasing redness, warmth, swelling, pain, and sometimes fever or malaise. Abscesses typically appear as tender, fluctuant, raised lesions with surrounding induration, while cellulitis presents with diffuse erythema that may include lymphangitic streaking. More severe presentations include systemic illness with signs of sepsis such as hypotension, tachycardia, altered mental status, or petechiae. CA-MRSA pneumonia may manifest with fever, rigors, dyspnea, chest pain, hypoxia, and productive cough, often progressing rapidly and associated with alveolar infiltrates on chest radiographs.
Evaluation depends on the severity and type of infection. Skin abscesses generally require incision and drainage, which is both diagnostic and therapeutic, with cultures often obtained to guide antibiotic selection due to evolving resistance patterns. In cases of suspected sepsis or pneumonia, prompt source identification, blood and urine cultures, chest imaging, and laboratory studies such as CBC and metabolic panels are indicated as resuscitation begins. Bedside ultrasound can be helpful in differentiating abscesses, which appear as anechoic fluid collections, from cellulitis, which demonstrates a “cobblestoning” pattern of subcutaneous edema.
Management in the emergency setting focuses on early recognition and appropriate treatment. Abscesses require incision and drainage, and antibiotics may be unnecessary in otherwise healthy patients without surrounding cellulitis or systemic signs. Cellulitis in stable patients can often be managed with oral antibiotics that provide coverage for CA-MRSA and streptococcal species, while ill-appearing patients or those with comorbidities require intravenous therapy. Patients with suspected sepsis, necrotizing infection, or pneumonia should receive early broad-spectrum antibiotics with MRSA coverage along with aggressive supportive care.
Antibiotic selection must take into account local resistance patterns, as CA-MRSA susceptibility varies by region. Commonly used agents include trimethoprim-sulfamethoxazole, clindamycin, doxycycline, vancomycin, linezolid, and rifampin (the latter never as monotherapy). Tetracyclines should be avoided during pregnancy, and prolonged use in children requires caution. Close follow-up is essential, with re-evaluation within 24–48 hours to ensure clinical improvement.
Hospital admission is warranted for patients with systemic illness, rapidly progressive infection, bacteremia, significant comorbidities such as diabetes or immunodeficiency, or failure of outpatient therapy. Well-appearing patients with uncomplicated skin and soft tissue infections may be safely discharged with appropriate antibiotics and follow-up instructions. Clinicians should remember that CA-MRSA is the leading cause of skin infections in the emergency department and, while often benign, can occasionally lead to severe and rapidly fatal disease if not promptly recognized and treated.
0 Comments
